A Phase Ib Study of the VEGF Receptor Tyrosine Kinase Inhibitor Tivozanib and Modified FOLFOX-6 in Patients With Advanced Gastrointestinal Malignancies

Corina N. Oldenhuis, Walter J. Loos, Brooke Esteves, Leni van Doorn, Monette M. Cotreau, Andrew L. Strahs, Martha W. den Hollander, Jourik A. Gietema, Elisabeth G. E. de Vries, Ferry A. L. M. Eskens*

*Corresponding author for this work

    Research output: Contribution to journal › Article › Academic › peer-review

    10 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'A Phase Ib Study of the VEGF Receptor Tyrosine Kinase Inhibitor Tivozanib and Modified FOLFOX-6 in Patients With Advanced Gastrointestinal Malignancies'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Keyphrases